Filter & sort
The latest funding rounds from the UK tech ecosystem. Updated 16 October 2026.
Announcements
1,485
Total raised
£42.6B
disclosed amounts
This month
£55.3M
raised so far
The funding round was co-led by Chroma Ventures and West Coast Capital to support technology development and global growth.
"We are very excited to have attracted investors of this calibre to Blippar. Not only is this a solid vote of confidence in Blippar’s technology from some of the most highly regarded industry veterans and business minds, but it also demonstrates sustained validation of the UK tech sector post-Brexit."
Ingka Investments backed the latest round to help the location technology firm scale into new global markets.
"what3words ambition is to become a global standard for communicating location"
The funding round was led by GV and will be used to expand the company assurance platform and launch insurance products.
"At a time of ongoing uncertainty, our goal is to provide confidence in a sector notorious for struggling to stick to deadlines or budgets. By using some of the most powerful machine learning capabilities in the world to analyse what worked and what didn’t in past projects, we can help our customers work out what’s going to derail their own initiatives, and stop problems happening before they even appear."
The seed round was backed by Trucks Venture Capital, Luminous Ventures and Jaguar Land Rover.
"AI has huge implications for the way businesses operate, yet so much of the modelling is done in carefully controlled test environments. When deployed in real world situations, anomalies always occur, which disrupts lab-grown models and undermines companies’ efforts to revolutionise how they use autonomous systems effectively. By scaling edge AI, optimising the endpoints collecting the data, and making models more resilient, we are radically accelerating learning and, in doing so, giving our customers a competitive advantage in a crowded marketplace."
The seed round was led by XTX Ventures and Prostate Cancer Research to support regulatory approvals and clinical studies.
"We are tremendously excited about the potential of this system to enhance our ability to detect cancer accurately and early. We are now looking forward to working with hospitals and radiology and urology partners to prove the technology and bring it into clinical use. Covid-19 has created a serious backlog in cancer screening and Lucida Medical is well placed to help us clear this and improve the care that we offer further over the coming years."
